NR1H4 and neoplasm: In the paper, they concluded that FXR may promote proliferation of HepG2 tumor cells by activating pyruvate dehydrogenate kinse4 (PDK4)-mediated metabolic reprogramming and generating glycolytic intermediates required for cell proliferation, which was not observed in healthy hepatocytes.